Pyrrolo[1,2-b]pyridazine-6-carboxylic acid
≥95%
- Product Code: 226371
CAS:
118768-13-1
Molecular Weight: | 162.15 g./mol | Molecular Formula: | C₈H₆N₂O₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD20646267 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, dry seal |
Product Description:
Used in pharmaceutical research as a key scaffold in the development of kinase inhibitors, particularly for targeting cancer-related enzymes. Its structure supports binding to ATP sites in proteins, making it valuable in designing drugs for oncology. Also explored in medicinal chemistry for central nervous system agents due to its ability to cross the blood-brain barrier. Serves as an intermediate in synthesizing bioactive molecules with anti-inflammatory and antiviral properties.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | £114.99 |
+
-
|
0.250 | 10-20 days | £286.22 |
+
-
|
1.000 | 10-20 days | £839.23 |
+
-
|
Pyrrolo[1,2-b]pyridazine-6-carboxylic acid
Used in pharmaceutical research as a key scaffold in the development of kinase inhibitors, particularly for targeting cancer-related enzymes. Its structure supports binding to ATP sites in proteins, making it valuable in designing drugs for oncology. Also explored in medicinal chemistry for central nervous system agents due to its ability to cross the blood-brain barrier. Serves as an intermediate in synthesizing bioactive molecules with anti-inflammatory and antiviral properties.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :